Table 2. Prognosticators of survival (DFS and OS) in patients with tongue cancer in various clinic-pathological parameters.
| S.No | Clinico-pathological parameter | Genes | Overall Survival Logrank Test P-Value |
Disease Free Survival Logrank Test P-Value# |
|---|---|---|---|---|
| 1 | Entire cohort (differential expression) | NUDCD1, TSTA3, MTFR1 and IGF2BP2 | 0.007 | 0.01 |
| 2 | Entire cohort | NUDCD1 | 0.0331 | 0.00958 |
| 3 | Stage I-II | C8ORF33 | 4.28e-03 | |
| OTUD6B | 0.0032 | |||
| MTFR1 | 0.0084 | |||
| 4 | Stage III-IV | NUDCD1 | 0.0253 | |
| CLPTM1L | 0.0285 | |||
| MAPRE1 | 0.034 | |||
| 5 | PNI + | NUDCD1 | 0.00187 | 0.0228 |
| TFG* | 0.019 | 0.0331 | ||
| BRIX1* | 0.0475 | 0.0437 | ||
| 6 | ALI + | PRKCI | 0.01 | |
| WDR70* | 0.0338 | |||
| BRIX1* | 0.0474 | |||
| 7 | Node+ ECS- | ANO1 | 0.00843 | 0.0133 |
| NUDCD1 | 0.00246 | 0.015 | ||
| ANO1, NUDCD1 and PIK3CA (Combination) | 6.545e-3 | 0.048 | ||
| 8 | Node+ ECS+ | GMPS | 0.0254 | |
| TSTA3 | 0.0373 | |||
| 9 | Stage I-II and PNI + | OTUD6B | 0.00166 | 0.0287 |
| 10 | Stage I-II and ALI + | OTUD6B | 0.0455 |
*Genes which are good prognosticators in their respective clinic-pathological parameter,
#genes were sorted based on DFS.